Evidence map›Paper›PMID 21408144›Full record

ArticlePloS one2011

Chlamydia species-dependent differences in the growth requirement for lysosomes.

Scot P Ouellette, Frank C Dorsey, Simon Moshiach, John L Cleveland, Rey A Carabeo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 82 citations in OpenAlex.

  1. Kaempferol inhibitsFrontiers in microbiology · 2026
    Article
  2. Macrophage vacuolar ATPase (v-ATPase) function controlsbioRxiv : the preprint server for biology · 2025
    Article
  3. Infection and immunity · 2024
    Article
  4. Review
  5. Autophagy: the misty lands ofFrontiers in cellular and infection microbiology · 2024
    Review
  6. Metabolism and physiology of pathogenic bacterial obligate intracellular parasites.Frontiers in cellular and infection microbiology · 2024
    Review
  7. ATG9A supportsMicrobiology spectrum · 2023
    Article
  8. Article
  9. Eat or Be Eaten: Strategies Used byInfection and immunity · 2023
    Review
  10. Article
  11. Establishing the intracellular niche of obligate intracellular vacuolar pathogens.Frontiers in cellular and infection microbiology · 2023
    Review
  12. Article
  13. Amino Acid Analog Induces Stress Response in MarineApplied and environmental microbiology · 2021
    Article
  14. Article
  15. Comparative Genome Analysis of 33Pathogens (Basel, Switzerland) · 2020
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Chlamydial Infection From Outside to Inside.Frontiers in microbiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Scot P OuelletteCentre for Molecular Microbiology and Infection, Division of Cell and Molecular Biology, Imperial College, London, United Kingdom.
Frank C Dorsey
Simon Moshiach
John L Cleveland
Rey A Carabeo
Imperial College London · GBScripps Research Institute · USSt. Jude Children's Research Hospital · US

Funding

CHLAMYDIAL INVASION OF NON-PHAGOCYTIC CELLSR01AI065545 · NIAID · WASHINGTON STATE UNIVERSITY · PI CARABEO, REY A · 2005 to 2021
$3.3M
Identification of the chlamydial adhesin and receptorK22AI052252 · NIAID · UNIVERSITY OF LOUISVILLE · PI CARABEO, REYNALDO A · 2004 to 2005
$216k
Understanding the Role of Autophagy in CancerF32CA123777 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI DORSEY, FRANK C · 2006 to 2009
$153k
Medical Research Council G0900213NCI NIH HHS CA123777NCI NIH HHS F32 CA123777NIAID NIH HHS AI052252NIAID NIH HHS AI065545NIAID NIH HHS K22 AI052252NIAID NIH HHS R01 AI065545
6 · The paper itself

Abstract

Genome reduction is a hallmark of obligate intracellular pathogens such as Chlamydia, where adaptation to intracellular growth has resulted in the elimination of genes encoding biosynthetic enzymes. Accordingly, chlamydiae rely heavily on the host cell for nutrients yet their specific source is unclear. Interestingly, chlamydiae grow within a pathogen-defined vacuole that is in close apposition to lysosomes. Metabolically-labeled uninfected host cell proteins were provided as an exogenous nutrient source to chlamydiae-infected cells, and uptake and subsequent labeling of chlamydiae suggested lysosomal degradation as a source of amino acids for the pathogen. Indeed, Bafilomycin A1 (BafA1), an inhibitor of the vacuolar H(+)/ATPase that blocks lysosomal acidification and functions, impairs the growth of C. trachomatis and C. pneumoniae, and these effects are especially profound in C. pneumoniae. BafA1 induced the marked accumulation of material within the lysosomal lumen, which was due to the inhibition of proteolytic activities, and this response inhibits chlamydiae rather than changes in lysosomal acidification per se, as cathepsin inhibitors also inhibit the growth of chlamydiae. Finally, the addition of cycloheximide, an inhibitor of eukaryotic protein synthesis, compromises the ability of lysosomal inhibitors to block chlamydial growth, suggesting chlamydiae directly access free amino acids in the host cytosol as a preferred source of these nutrients. Thus, chlamydiae co-opt the functions of lysosomes to acquire essential amino acids.

Indexed as

Amino AcidsAnimalsAutophagyCattleChlamydiaCycloheximideCytosolGene Knockdown TechniquesHumansInclusion BodiesLysosomesMacrolidesMiceModels, BiologicalPositive Transcriptional Elongation Factor BProtein Processing, Post-TranslationalAmino Acidsbafilomycin A1CycloheximideMacrolidesPositive Transcriptional Elongation Factor BSerum Albumin, Bovine

Identifiers

PMID21408144
PMCPMC3050816
OpenAlexW1972835818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.